Table of Content

1 Research Methodology

2 Research Objectives

3 Research Process


4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusion
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Test
4.4.3 Market Segmentation by Disease
4.4.4 Market Segmentation by End-User
4.4.5 Market Segmentation by Geography


5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation


6 Market at a Glance

7 Introduction
7.1 Overview


8 Market Opportunities & Trends
8.1 High Growth Potential In Low And Middle Income Countries (LMICS)
8.2 Increasing Demand For Molecular Diagnostics
8.3 Strategic Merges and Acquisitions


9 Market Growth Enablers
9.1 Increase In The Worldwide Prevalence Of Infectious Diseases
9.2 Shift From Centralized Laboratories To Point Of Care Testing
9.3 Technological Advancements And Launch Of More Reliable Products


10 Market Restraints
10.1 Availability of Advanced Control Mechanism For Infectious Disease
10.2 Inadequate Reimbursement
10.3 Poor Healthcare Infrastructure And Less Affordability In LMICS


11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry


12 Test
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Traditional Diagnostics
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Molecular Diagnostics
12.4.1 Market Overview
12.4.2 Market Size & Forecast


13 Disease
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hepatitis
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 HIV
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Hospital Acquired Infections (HAIs)
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.6 Influenza
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.7 Tuberculosis
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.8 Malaria
13.8.1 Market Overview
13.8.2 Market Size & Forecast
13.9 Human Papilloma Virus
13.9.1 Market Overview
13.9.2 Market Size & Forecast
13.10 SEPSIS
13.10.1 Market Overview
13.10.2 Market Size & Forecast
13.11 Dengue
13.11.1 Market Overview
13.11.2 Market Size & Forecast
13.12 Other Infectious Diseases
13.12.1 Market Overview
13.12.2 Market Size & Forecast


14 Product
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Consumables
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Instruments/Analyzers & Software
14.4.1 Market Overview
14.4.2 Market Size & Forecast


15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Standard Reference Laboratories
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Public Health Laboratories
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Blood Banks
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Acute Care Settings
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Other End-User
15.8.1 Market Overview
15.8.2 Market Size & Forecast


16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview


17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 China: Market Size & Forecast
17.3.2 Japan: Market Size & Forecast
17.3.3 India: Market Size & Forecast
17.3.4 South Korea: Market Size & Forecast
17.3.5 Australia: Market Size & Forecast


18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast


19 North America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 US: Market Size & Forecast
19.3.2 Canada: Market Size & Forecast


20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast


21 Middle East and Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Key Countries
21.3.1 South Africa: Market Size & Forecast
21.3.2 Turkey: Market Size & Forecast
21.3.3 Saudi Arabia: Market Size & Forecast
21.3.4 Iran: Market Size & Forecast


22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Abbott
22.2.2 BD
22.2.3 bioM?rieux
22.2.4 DANAHER
22.2.5 Bio-Rad Laboratories
22.2.6 F.Hoffmann-LaRoche
22.2.7 Luminex
22.2.8 Quidel
22.2.9 Thermo Fischer Scientific


23 Key Company Profiles
23.1 Abbott
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 BD
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 bioM?rieux
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 F.Hoffmann-La Roche
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Thermo Fisher Scientific
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Quidel
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 Luminex
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
23.8 Danaher
23.8.1 Business Overview
23.8.2 Product Offerings
23.8.3 Key Strategies
23.8.4 Key Strengths
23.8.5 Key Opportunities
23.9 Bio-Rad Laboratories
23.9.1 Business Overview
23.9.2 Product Offerings
23.9.3 Key Strategies
23.9.4 Key Strengths
23.9.5 Key Opportunities

24 Other Prominent Vendors
24.1 Meridian Bioscience
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 DiaSorin Molecular
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Accelerate Diagnostics
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Trinity Biotech
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 OpGen
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Qiagen
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Siemens Healthineers
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 cavidi
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 EIKEN Chemical
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Epitope Diagnostics
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Euroimmun
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Genetic Signatures
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Hologic
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Oxford Immunotec
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Seegene
24.15.1 Business Overview
24.15.2 Product Offerings

25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations

26 Quantitative Summary
26.1 Market By Geography
26.2 Market By End-User
26.3 Market By Test
26.4 Market By Product
26.5 Market By Disease

27 Appendix
27.1 Abbreviations